跳至主要内容
临床试验/CTRI/2020/05/025307
CTRI/2020/05/025307尚未招募未知

To evaluate the overall therapeutic benefit in terms of tumour response, quality of life and adherence to anticancer therapy in real world cancer patients taking Rasayana therapy along with conventional anticancer therapies.

Rasayu Cancer Clinic Pune0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Biopsy or Histopathologically confirmed any stage Cancer
  • 2 Have taken more than 6 months of Rasayana therapy and Completed chemotherapy treatment simultaneously

排除标准

  • 1. Diagnosed cases of carcinoma of stage I and II
  • 2. Those patients who are not ready for the study.
  • 3. Patients taking Radiotherapy.
  • 4. Patients have taken less than 6 months of Rasayana Therapy
  • 5. Patients with an expected survival of less than 3 months

研究者

发起方
Rasayu Cancer Clinic Pune

相似试验